Literature DB >> 26718437

Associations between interleukin-1 and IL-1 receptor antagonist polymorphisms and susceptibility to rheumatoid arthritis: A meta-analysis.

Y H Lee1, S-C Bae2.   

Abstract

This study determined whether interleukin-1 (IL-1) polymorphisms are associated with susceptibility to rheumatoid arthritis (RA). A meta-analysis was conducted on the associations between the IL-1A, IL-1B, and IL-1 receptor antagonist (IL-1RN) polymorphisms and RA. A total of 16 studies involving 4,339 RA cases and 3,885 controls were included in the meta-analysis. Meta-analysis of the IL-1B -511 C/T polymorphism revealed an association between the IL-1B -511 T allele and RA in Caucasians (OR = 0.913, 95% CI = 0.840-0.992, p = 0.031), but not in Asians. Ethnicity-specific meta-analysis indicated an association between the TT+TC genotype of the IL-1B 3953 C/T polymorphism and RA in Caucasians (OR = 1.243, 95% CI = 1.008-1.533, p = 0.042) and in Asians (OR = 2.672, 95% CI = 1.662-4.296, p = 4.9x10-6). No association was between RA susceptibility and the IL-1A -889 C/T, IL-1A +4845 G/T, and IL-1RN +2018 C/T polymorphisms. This meta-analysis suggests the IL-1B -511 C/T polymorphism is associated with susceptibility to RA in Caucasians, and that the IL-1B +3953 C/T polymorphism is associated with susceptibility to RA in Caucasians and Asians.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26718437

Source DB:  PubMed          Journal:  Cell Mol Biol (Noisy-le-grand)        ISSN: 0145-5680            Impact factor:   1.770


  6 in total

1.  Advances in Disease Mechanisms and Translational Technologies: Clinicopathologic Significance of Inflammasome Activation in Autoimmune Diseases.

Authors:  J Michelle Kahlenberg; Insoo Kang
Journal:  Arthritis Rheumatol       Date:  2020-01-15       Impact factor: 10.995

2.  Association of 86 bp variable number of tandem repeat (VNTR) polymorphism of interleukin-1 receptor antagonist (IL1RN) with susceptibility and clinical activity in rheumatoid arthritis.

Authors:  S Ramírez-Pérez; M Salazar-Páramo; S Pineda-Monjarás; U De la Cruz-Mosso; J Hernández-Bello; G E Martínez-Bonilla; A L Pereira-Suárez; J F Muñoz-Valle
Journal:  Clin Rheumatol       Date:  2017-03-25       Impact factor: 2.980

3.  Author`s Reply.

Authors:  Ferit Onur Mutluer; Dilek Ural; Barış Güngör; Osman Bolca; Tolga Aksu
Journal:  Anatol J Cardiol       Date:  2018-03       Impact factor: 1.596

4.  Meta-analyses of IL1A polymorphisms and the risk of several autoimmune diseases published in databases.

Authors:  Hang Su; Na Rei; Lei Zhang; Jiaxiang Cheng
Journal:  PLoS One       Date:  2018-06-07       Impact factor: 3.240

Review 5.  Role of inflammasomes in the pathogenesis of periodontal disease and therapeutics.

Authors:  Julie T Marchesan; Mustafa Saadat Girnary; Kevin Moss; Eugenia Timofeev Monaghan; Grant Joseph Egnatz; Yizu Jiao; Shaoping Zhang; Jim Beck; Karen V Swanson
Journal:  Periodontol 2000       Date:  2020-02       Impact factor: 7.589

Review 6.  Ultra-Low Dose Cytokines in Rheumatoid Arthritis, Three Birds with One Stone as the Rationale of the 2LARTH® Micro-Immunotherapy Treatment.

Authors:  Camille Jacques; Ilaria Floris; Béatrice Lejeune
Journal:  Int J Mol Sci       Date:  2021-06-23       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.